News & Views
Michael McKelvey Retires from ERT
Mar 15 2011
ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries announced the retirement of President and CEO Dr. Michael J. McKelvey, at the year end, with Dr Joel Morganroth currently taking up the position prior to hiring a permanent replacement.
Dr Morganroth has served as the Chairman of ERT’s Board of Directors since 1999 and as Chief Scientific Officer since April 2006. He previously served as the company’s Chief Executive Officer from 1993 to March 2001 and also has consulted for ERT since 1977. Dr Morganroth is also a globally recognised cardiologist and clinical researcher and has had more than 10 years’ experience as a medical review officer/expert for the U.S. Food and Drug Administration (FDA).
Dr Morganroth commented: “We thank Dr.McKelvey for his years of service and wish him well in his future endeavours.”
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 03 2024 Gandhinagar, India
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA